{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T06:30:29Z","timestamp":1787812229072,"version":"build-2784847793"},"reference-count":30,"publisher":"Harborside Press, LLC","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,11]]},"abstract":"<jats:p>\n                    <jats:bold>Background:<\/jats:bold>\n                    Digital breast tomosynthesis (DBT) has been less extensively evaluated for surveillance after breast cancer treatment than for screening. We compared the performance of DBT and digital mammography (DM) for surveillance of asymptomatic women with a personal history of breast cancer (PHBC), using US clinical practice data adjusted for population differences.\n                    <jats:bold>Methods:<\/jats:bold>\n                    We conducted a retrospective cohort study of 28,042 women with PHBC and posttreatment surveillance mammograms performed between 2012 and 2018 at 37 facilities within the Breast Cancer Surveillance Consortium. We calculated performance measures and absolute differences (ADs) for DBT versus DM, including cancer detection rate (CDR), invasive CDR, interval cancer rate, recall rate, and false-positive biopsy recommendation rate, sensitivity, specificity, and positive predictive value (PPV1), with 95% confidence intervals, adjusting for population characteristics using overlap weighting.\n                    <jats:bold>Results:<\/jats:bold>\n                    Among 80,077 mammograms (DBT, n=27,852; DM, n=52,225) and 1,098 subsequent breast cancer diagnoses, DBT had a higher CDR (AD, 2.3 per 1,000 [95% CI, 0.3 to 4.3]), invasive CDR (AD, 2.9 per 1,000 [95% CI, 1.0 to 4.7]), and PPV1 (AD, 5.2% [95% CI, 2.5% to 7.8%)] and lower recall rate (AD, \u20131.0% [95% CI, \u20131.5% to \u22120.5%]) compared with DM. No significant differences overall were identified for interval cancer rate or other performance measures. Surveillance-detected cancers with DBT or DM had similar proportions of favorable prognostic characteristics (smaller size, node-negative, and estrogen receptor\u2013positive).\n                    <jats:bold>Conclusions:<\/jats:bold>\n                    For women with PHBC, DBT had better detection metrics compared with DM, as demonstrated by higher CDR, higher invasive CDR, and lower recall rate. However, the lack of significant reduction in interval cancer rate suggests that both DBT and DM may be used for posttreatment surveillance. Identifying effective imaging surveillance strategies for reducing interval cancer rates is needed to further improve posttreatment outcomes.\n                  <\/jats:p>","DOI":"10.6004\/jnccn.2025.7057","type":"journal-article","created":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T14:24:44Z","timestamp":1760624684000},"page":"445-452","source":"Crossref","is-referenced-by-count":2,"title":["Comparative Accuracy of Digital Breast Tomosynthesis and Digital Mammography for Surveillance After Breast Cancer Treatment"],"prefix":"10.6004","volume":"23","author":[{"given":"Janie M.","family":"Lee","sequence":"first","affiliation":[{"name":"Department of Radiology, University of Washington School of Medicine, Seattle, WA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Ichikawa","sequence":"additional","affiliation":[{"name":"Biostatistics Division, Kaiser Permanente Washington Health Research Institute, Seattle, WA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Ru","family":"Su","sequence":"additional","affiliation":[{"name":"Biostatistics Division, Kaiser Permanente Washington Health Research Institute, Seattle, WA"},{"name":"Department of Biostatistics, University of Washington, Seattle, WA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naomi","family":"Noguchi","sequence":"additional","affiliation":[{"name":"Faculty of Medicine and Health, Sydney School of Public Health, University of Sydney, Sydney, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca A.","family":"Hubbard","sequence":"additional","affiliation":[{"name":"Department of Biostatistics, Epidemiology, and Informatics, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA"},{"name":"Department of Biostatistics, Brown University School of Public Health, Providence, RI"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karla","family":"Kerlikowske","sequence":"additional","affiliation":[{"name":"Departments of Medicine, and Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer M.","family":"Specht","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Washington School of Medicine, Seattle, WA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellen S.","family":"O\u2019Meara","sequence":"additional","affiliation":[{"name":"Biostatistics Division, Kaiser Permanente Washington Health Research Institute, Seattle, WA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louise M.","family":"Henderson","sequence":"additional","affiliation":[{"name":"Department of Radiology, University of North Carolina at Chapel Hill, Chapel Hill, NC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nehmat","family":"Houssami","sequence":"additional","affiliation":[{"name":"Faculty of Medicine and Health, Sydney School of Public Health, University of Sydney, Sydney, Australia"},{"name":"Daffodil Centre, University of Sydney, a Joint Venture With Cancer Council NSW, Sydney, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"4047","reference":[{"key":"B1","series-title":"N Engl J Med","first-page":"1773","article-title":"Diagnostic performance of digital versus film mammography for breast-cancer screening","volume":"353","author":"Pisano ED","year":"2005","unstructured":"Pisano ED, Gatsonis C, Hendrick E,  Diagnostic performance of digital versus film mammography for breast-cancer screening. N Engl J Med 2005;353:1773\u20131783."},{"key":"B2","series-title":"Radiology","first-page":"e222499.","article-title":"National performance benchmarks for screening digital breast tomosynthesis: update from the Breast Cancer Surveillance Consortium","volume":"307","author":"Lee CI","year":"2023","unstructured":"Lee CI, Abraham L, Miglioretti DL,  National performance benchmarks for screening digital breast tomosynthesis: update from the Breast Cancer Surveillance Consortium. Radiology 2023;307:e222499."},{"key":"B3","series-title":"Radiology","first-page":"e233142.","article-title":"Digital breast tomosynthesis versus digital mammography screening performance on successive screening rounds from the Breast Cancer Surveillance Consortium","volume":"307","author":"Sprague BL","year":"2023","unstructured":"Sprague BL, Coley RY, Lowry KP,  Digital breast tomosynthesis versus digital mammography screening performance on successive screening rounds from the Breast Cancer Surveillance Consortium. Radiology 2023;307:e233142."},{"key":"B4","series-title":"Radiology","first-page":"e221571.","article-title":"Mammographic screening in routine practice: multisite study of digital breast tomosynthesis and digital mammography screenings","volume":"307","author":"Conant EF","year":"2023","unstructured":"Conant EF, Talley MM, Parghi CR,  Mammographic screening in routine practice: multisite study of digital breast tomosynthesis and digital mammography screenings. Radiology 2023;307:e221571."},{"key":"B5","unstructured":"U.S. Food and Drug Administration. MQSA national statistics. Accessed August 8, 2024. Available at: https:\/\/www.fda.gov\/radiation-emitting-products\/mammography-information-patients\/mqsa-national-statistics"},{"key":"B6","series-title":"Breast","first-page":"439","article-title":"Mammographic surveillance in women with a personal history of breast cancer: how accurate? How effective?","volume":"19","author":"Houssami N","year":"2010","unstructured":"Houssami N, Ciatto S. Mammographic surveillance in women with a personal history of breast cancer: how accurate? How effective? Breast 2010;19:439\u2013445."},{"key":"B7","series-title":"Eur J Cancer","first-page":"3000","article-title":"The value of surveillance mammography of the contralateral breast in patients with a history of breast cancer","volume":"45","author":"Lu W","year":"2009","unstructured":"Lu W, Schaapveld M, Jansen L,  The value of surveillance mammography of the contralateral breast in patients with a history of breast cancer. Eur J Cancer 2009;45:3000\u20133007."},{"key":"B8","series-title":"Breast Cancer Res Treat","first-page":"403","article-title":"Impact on survival of early detection of isolated breast recurrences after the primary treatment for breast cancer: a meta-analysis","volume":"114","author":"Lu WL","year":"2009","unstructured":"Lu WL, Jansen L, Post WJ,  Impact on survival of early detection of isolated breast recurrences after the primary treatment for breast cancer: a meta-analysis. Breast Cancer Res Treat 2009;114:403\u2013412."},{"key":"B9","series-title":"Breast Cancer Res Treat","first-page":"61","article-title":"Reduced rates of cancer-related worries and mortality associated with guideline surveillance after breast cancer therapy","volume":"89","author":"Lash TL","year":"2005","unstructured":"Lash TL, Clough-Gorr K, Silliman RA. Reduced rates of cancer-related worries and mortality associated with guideline surveillance after breast cancer therapy. Breast Cancer Res Treat 2005;89:61\u201367."},{"key":"B10","series-title":"J Clin Oncol","first-page":"3001","article-title":"Mammography surveillance and mortality in older breast cancer survivors","volume":"25","author":"Lash TL","year":"2007","unstructured":"Lash TL, Fox MP, Buist DSM,  Mammography surveillance and mortality in older breast cancer survivors. J Clin Oncol 2007;25:3001\u20133006."},{"key":"B11","series-title":"Breast J","first-page":"2","article-title":"Reduced mortality rate associated with annual mammograms after breast cancer therapy","volume":"12","author":"Lash TL","year":"2006","unstructured":"Lash TL, Fox MP, Silliman RA. Reduced mortality rate associated with annual mammograms after breast cancer therapy. Breast J 2006;12:2\u20136."},{"key":"B12","series-title":"Breast Cancer Res Treat","first-page":"153","article-title":"Breast cancer outcomes in older women: long-term surveillance mammography and mortality in older women with a history of early stage invasive breast cancer","volume":"142","author":"Buist DSM","year":"2013","unstructured":"Buist DSM, Bosco JLF, Silliman RA,  Breast cancer outcomes in older women: long-term surveillance mammography and mortality in older women with a history of early stage invasive breast cancer. Breast Cancer Res Treat 2013;142:153\u2013163."},{"key":"B13","series-title":"Breast Cancer Res Treat","first-page":"863","article-title":"Diagnosis of second breast cancer events after initial diagnosis of early stage breast cancer","volume":"124","author":"Buist DSM","year":"2010","unstructured":"Buist DSM, Abraham LA, Barlow WE,  Diagnosis of second breast cancer events after initial diagnosis of early stage breast cancer. Breast Cancer Res Treat 2010;124:863\u2013873."},{"key":"B14","series-title":"JAMA","first-page":"790","article-title":"Accuracy and outcomes of screening mammography in women with a personal history of early-stage breast cancer","volume":"305","author":"Houssami N","year":"2011","unstructured":"Houssami N, Abraham LA, Miglioretti DL,  Accuracy and outcomes of screening mammography in women with a personal history of early-stage breast cancer. JAMA 2011;305:790\u2013799."},{"key":"B15","series-title":"Radiology","first-page":"290","article-title":"Digital mammography performance and outcomes in women with a personal history of breast cancer, 2007\u20132016","volume":"300","author":"Lee JM","year":"2021","unstructured":"Lee JM, Ichikawa LE, Wernli KJ,  Digital mammography performance and outcomes in women with a personal history of breast cancer, 2007\u20132016. Radiology 2021;300:290\u2013300."},{"key":"B16","series-title":"Radiology","first-page":"308","article-title":"Imaging surveillance of breast cancer survivors with digital mammography versus digital breast tomosynthesis","volume":"298","author":"Bahl M","year":"2021","unstructured":"Bahl M, Mercaldo S, McCarthy AM, Lehman CD. Imaging surveillance of breast cancer survivors with digital mammography versus digital breast tomosynthesis. Radiology 2021;298:308\u2013316."},{"key":"B17","series-title":"AJR Am J Roentgenol","first-page":"587","article-title":"Screening mammography performance metrics of 2D digital mammography versus digital breast tomosynthesis in women with a personal history of breast cancer","volume":"217","author":"Chikarmane SA","year":"2021","unstructured":"Chikarmane SA, Cochon L, Khorasani R,  Screening mammography performance metrics of 2D digital mammography versus digital breast tomosynthesis in women with a personal history of breast cancer. AJR Am J Roentgenol 2021;217:587\u2013594."},{"key":"B18","series-title":"AJR Am J Roentgenol","first-page":"32330419","article-title":"Performance metrics of screening digital breast tomosynthesis based on years since a prior breast cancer diagnosis","volume":"222","author":"Do D","year":"2024","unstructured":"Do D, Mercaldo S, Bahl M. Performance metrics of screening digital breast tomosynthesis based on years since a prior breast cancer diagnosis. AJR Am J Roentgenol 2024;222:32330419."},{"key":"B19","series-title":"Radiography (Lond)","first-page":"975","article-title":"Comparing the performance of full-field digital mammography and digital breast tomosynthesis in the post- treatment surveillance of patients with a history of breast cancer: a retrospective study","volume":"29","author":"Nia E","year":"2023","unstructured":"Nia E, Patel M, Kapoor M,  Comparing the performance of full-field digital mammography and digital breast tomosynthesis in the post- treatment surveillance of patients with a history of breast cancer: a retrospective study. Radiography (Lond) 2023;29:975\u2013979."},{"key":"B20","article-title":"AJCC Cancer Staging Manual","year":"2017","unstructured":"American Joint Commission on Cancer. AJCC Cancer Staging Manual, 8th ed. Springer International Publishing; 2017."},{"key":"B21","unstructured":"American College of Radiology. American College Practice Parameter for the Performance of Screening and Diagnostic Mammography. Accessed May 25, 2024. Available at: https:\/\/www.acr.org\/-\/media\/ACR\/Files\/Practice-Parameters\/screen-diag-mammo.pdf?la=en"},{"key":"B22","article-title":"Breast Imaging Reporting and Data System Atlas (BI-RADS).","year":"2013","unstructured":"American College of Radiology. Breast Imaging Reporting and Data System Atlas (BI-RADS). American College of Radiology; 2013."},{"key":"B23","series-title":"J Amer Stat Assoc","first-page":"390","article-title":"Balancing covariates via propensity score weighting","volume":"113","author":"Li F","year":"2018","unstructured":"Li F, Morgan KL, Zaslavsky AM. Balancing covariates via propensity score weighting. J Amer Stat Assoc 2018;113:390\u2013400."},{"key":"B24","series-title":"Radiology","first-page":"9","article-title":"New screening technologies and practices: a different approach to estimation of performance improvement by using data from the transition period","volume":"275","author":"Gur D","year":"2015","unstructured":"Gur D, Nishikawa RM, Sumkin JH. New screening technologies and practices: a different approach to estimation of performance improvement by using data from the transition period. Radiology 2015;275:9\u201312."},{"key":"B25","series-title":"J Natl Cancer Inst","first-page":"370","article-title":"Method of primary breast cancer detection and the disease-free interval, adjusting for lead time","volume":"116","author":"de Munck L","year":"2024","unstructured":"de Munck L, Eijkelboom AH, Otten JDM,  Method of primary breast cancer detection and the disease-free interval, adjusting for lead time. J Natl Cancer Inst 2024;116:370\u2013378."},{"key":"B26","series-title":"Am J Epidemiol","first-page":"98","article-title":"Correcting for lead time and length bias in estimating the effect of screen detection on cancer survival","volume":"168","author":"Duffy SW","year":"2008","unstructured":"Duffy SW, Nagtegaal ID, Wallis M,  Correcting for lead time and length bias in estimating the effect of screen detection on cancer survival. Am J Epidemiol 2008;168:98\u2013104."},{"key":"B27","series-title":"Radiology","first-page":"e231533.","article-title":"Digital breast tomosynthesis versus digital mammography for detection of early-stage cancers stratified by grade: a TOSYMA subanalysis","volume":"309","author":"Weigel S","year":"2023","unstructured":"Weigel S, Heindel W, Decker T,  Digital breast tomosynthesis versus digital mammography for detection of early-stage cancers stratified by grade: a TOSYMA subanalysis. Radiology 2023;309:e231533."},{"key":"B28","series-title":"Radiology","first-page":"e221006","article-title":"Breast density and breast cancer screening with digital breast tomosynthesis: a TOSYMA trial subanalysis","volume":"306","author":"Weigel S","year":"2023","unstructured":"Weigel S, Heindel W, Hense HW,  Breast density and breast cancer screening with digital breast tomosynthesis: a TOSYMA trial subanalysis. Radiology 2023;306:e221006."},{"key":"B29","article-title":"PROSPECTS trial","unstructured":"NHS Health Research Authority. PROSPECTS trial. Accessed July 23, 2024. Available at: https:\/\/www.hra.nhs.uk\/planning-and-improving-research\/application-summaries\/research-summaries\/prospects\/"},{"key":"B30","series-title":"J Am Coll Radiol","first-page":"755","article-title":"Facility variability in examination indication among women with prior breast cancer: Implications and the need for standardization","volume":"17","author":"Buist DSM","year":"2020","unstructured":"Buist DSM, Ichikawa L, Wernli KJ,  Facility variability in examination indication among women with prior breast cancer: Implications and the need for standardization. J Am Coll Radiol 2020;17:755\u2013764."}],"container-title":["Journal of the National Comprehensive Cancer Network"],"original-title":[],"link":[{"URL":"https:\/\/jnccn.org\/view\/journals\/jnccn\/23\/11\/article-p445.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/jnccn.org\/downloadpdf\/journals\/jnccn\/23\/11\/article-p445.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/jnccn.org\/downloadpdf\/journals\/jnccn\/23\/11\/article-p445.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,10]],"date-time":"2025-11-10T13:56:40Z","timestamp":1762783000000},"score":1,"resource":{"primary":{"URL":"https:\/\/jnccn.org\/view\/journals\/jnccn\/23\/11\/article-p445.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":30,"journal-issue":{"issue":"11"},"URL":"https:\/\/doi.org\/10.6004\/jnccn.2025.7057","relation":{},"ISSN":["1540-1405","1540-1413"],"issn-type":[{"value":"1540-1405","type":"print"},{"value":"1540-1413","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11]]}}}